Korean J Nucl Med.  1998 Jun;32(3):211-224.

Changing Role of Nuclear Medicine for the Evaluation of Focal Hepatic Tumors: From Lesion Detection to Tissue Characterization

Abstract

The role of scintigraphic imaging has moved from the detection of lesions to the tissue-specific characterization of lesions over the past 2 decades. Major advances in nuclear medicine imaging include: 1) positron imaging, 2) improved instrumentation, such as the use of multidetector (dual or triple head) gamma cameras for single photon emission computed tomography, and 3) development of numerous new radiopharmaceuticals for positron or single photon imaging ( labeled glucose analogue, amino acids, fatty acids, hormones, drugs, receptor ligands, monoclonal antibodies, etc). These advanced have resulted in a significantly improved efficacy of radionuclide techniques for the evaluation of various of focal gepatic tumors is reviewed in this article with an emphasis on the clinical applications of various tracer studies and imaging findings.

Keyword

Radionuclide imaging; Liver tumors; Hepatocellular carcinoma; Hemangioma; Liver metastasis

MeSH Terms

Amino Acids
Antibodies, Monoclonal
Carcinoma, Hepatocellular
Electrons
Fatty Acids
Gamma Cameras
Glucose
Hemangioma
Ligands
Nuclear Medicine*
Radionuclide Imaging
Radiopharmaceuticals
Tomography, Emission-Computed, Single-Photon
Amino Acids
Antibodies, Monoclonal
Fatty Acids
Glucose
Ligands
Radiopharmaceuticals
Full Text Links
  • KJNM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr